Narcolepsy 3 C1836907
A sleep disorder causing overwhelming daytime drowsiness and disrupted nighttime sleep. While there's no cure, medications and sleep schedule adjustments can help manage symptoms.
Key facts at a glance
- ICD-10
- G43.909
- ICD-11
- 8A00.0
- Body system
- neurologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Cataplexy
Excessive daytime sleepiness
(neurologic)Generalized symptoms
(neurologic)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Sleep fragmentation
(neurologic)Automatic behaviors
(neurologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Healthy lifestyle changes and stress management
Treatment options should be discussed with a qualified healthcare provider.
Wake-Promoting Agents
Pharmacological stimulants that enhance alertness by modulating dopamine and other neurotransmitters involved in wakefulness regulation.
Strategic Power Napping
Implementation of brief, timed daytime naps as a non-pharmacological strategy to reduce sleep pressure and improve afternoon alertness.
Additional treatment options
Tricyclic/SNRI Antidepressants for Cataplexy
Medications that reduce cataplexy episodes by increasing norepinephrine and serotonin levels, addressing emotional triggers for muscle atonia.
medicationLow-Carbohydrate, High-Protein Meal Planning
Dietary modifications that minimize postprandial drowsiness through balanced macronutrient distribution and avoidance of high-glycemic foods.
dietaryPolysomnography with Multiple Sleep Latency Test
Diagnostic monitoring to confirm diagnosis and assess treatment efficacy through objective measurement of sleep latency and REM onset episodes.
monitoringWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Narcolepsy 3 C1836907?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Sullivan SS, Kushida CA, Belis ZA. American Academy of Sleep Medicine Practice Parameters for the Treatment of Narcolepsy and Hypersomnias. J Clin Sleep Med. 2021.
Kornum BR, Pizza F, Knudsen S, Plazzi G. Cerebrospinal fluid hypocretin measures in narcolepsy: update on clinical applicability. Sleep Med Rev. 2019.
Barateau L, Libala R, Nielsen T, Arnulf I. Solriamfetol for Excessive Daytime Sleepiness in Narcolepsy Type 2: Efficacy and Safety Results. Sleep. 2022.
Moresco M, Taddio N, Rishi MA, Ferri R. Immunopathogenesis of Narcolepsy Type 2: A Systematic Review and Meta-Analysis. Brain Sci. 2023.
Medication Comparisons
Compare medications used to treat Narcolepsy 3 C1836907. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy